Constance Keyserling
Chief Operating Officer bei ABIONYX PHARMA
Profil
Constance Keyserling is currently the Director of Clinical Development & Operations at ABIONYX Pharma SA. Previously, she held positions as the Senior Director of Operations at Esperion Therapeutics, Inc., Manager of Clinical Research Operations at Pfizer Inc., Vice President of Development Operations at QuatRx Pharmaceuticals Co., and Manager of Clinical Research Operations at Parke, Davis & Co. LLC.
She obtained her graduate degree from Harvard University in 1984.
Aktive Positionen von Constance Keyserling
Unternehmen | Position | Beginn |
---|---|---|
ABIONYX PHARMA | Chief Operating Officer | - |
Ehemalige bekannte Positionen von Constance Keyserling
Unternehmen | Position | Ende |
---|---|---|
PFIZER, INC. | Corporate Officer/Principal | - |
ESPERION THERAPEUTICS, INC. | Chief Operating Officer | - |
Parke, Davis & Co. LLC | Corporate Officer/Principal | - |
QuatRx Pharmaceuticals Co.
QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Corporate Officer/Principal | - |
Ausbildung von Constance Keyserling
Harvard University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
PFIZER, INC. | Health Technology |
ESPERION THERAPEUTICS, INC. | Health Technology |
ABIONYX PHARMA | Health Technology |
Private Unternehmen | 2 |
---|---|
QuatRx Pharmaceuticals Co.
QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Health Technology |
Parke, Davis & Co. LLC |